变构调节
西酞普兰
再摄取
5-羟色胺能
化学
抗抑郁药
再摄取抑制剂
5-羟色胺质膜转运蛋白
生物物理学
血清素转运体
血清素
药理学
神经递质转运体
生物化学
神经递质
神经科学
生物
受体
海马体
作者
Jonathan A. Coleman,Evan M. Green,Eric Gouaux
出处
期刊:Nature
[Springer Nature]
日期:2016-04-04
卷期号:532 (7599): 334-339
被引量:579
摘要
The serotonin transporter (SERT) terminates serotonergic signalling through the sodium- and chloride-dependent reuptake of neurotransmitter into presynaptic neurons. SERT is a target for antidepressant and psychostimulant drugs, which block reuptake and prolong neurotransmitter signalling. Here we report X-ray crystallographic structures of human SERT at 3.15 Å resolution bound to the antidepressants (S)-citalopram or paroxetine. Antidepressants lock SERT in an outward-open conformation by lodging in the central binding site, located between transmembrane helices 1, 3, 6, 8 and 10, directly blocking serotonin binding. We further identify the location of an allosteric site in the complex as residing at the periphery of the extracellular vestibule, interposed between extracellular loops 4 and 6 and transmembrane helices 1, 6, 10 and 11. Occupancy of the allosteric site sterically hinders ligand unbinding from the central site, providing an explanation for the action of (S)-citalopram as an allosteric ligand. These structures define the mechanism of antidepressant action in SERT, and provide blueprints for future drug design.
科研通智能强力驱动
Strongly Powered by AbleSci AI